Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

ACTI-I CAPLET 0.225 MG

IODINE (KELP, POTASSIUM IODIDE) : 0.225 MG · DIN 00899127 · ACTI-FORM LTD.

Health Canada status: CANCELLED POST MARKET

What is ACTI-I CAPLET?

ACTI-I CAPLET 0.225 MG contains IODINE (KELP, POTASSIUM IODIDE) : 0.225 MG. It is listed in the Health Canada Drug Product Database under DIN 00899127, held by ACTI-FORM LTD., supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 21-Mar-2005. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

Product details and regulatory record

DIN00899127
Brand nameACTI-I CAPLET
Generic / active ingredientIODINE (KELP, POTASSIUM IODIDE) : 0.225 MG
ManufacturerACTI-FORM LTD.
Strength0.225 MG
Dosage formTABLET
Route of administrationORAL
ScheduleNON-PRESCRIPTION DRUGS
ATC codeA12CX OTHER MINERAL PRODUCTS
AHFS class28:08.92 ; 04:04.20
BiosimilarNo
Health Canada statusCANCELLED POST MARKET
Status date21-Mar-2005
Original market date1992-12-31 00:00:00

What can be used instead?

Other Canadian products sharing ATC code A12CX OTHER MINERAL PRODUCTS. 5 of 75 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
MICRO CR4 MCGSOLUTIONSANDOZ CANADA INCORPORATEDMARKETEDDIN 00786985
MICRO CU0.4 MGSOLUTIONSANDOZ CANADA INCORPORATEDMARKETEDDIN 00786969
MICRO I100 MCGLIQUIDSANDOZ CANADA INCORPORATEDMARKETEDDIN 01974548
MICRO MN0.1 MGSOLUTIONSANDOZ CANADA INCORPORATEDMARKETEDDIN 00786942
MICRO SE40 MCGSOLUTIONSANDOZ CANADA INCORPORATEDMARKETEDDIN 01986007
ACTICHROM200 MCGTABLETNUTRACEUTICAL CORPORATIONCANCELLED (UNRETURNED ANNUAL)DIN 02241135
ACTYFORM1 MGCAPSULETECHNODIET S.E.N.C.CANCELLED POST MARKETDIN 02240282
BIO-CHROME200 MCGCAPSULESANTÉ NATURELLE (AG) LTÉECANCELLED POST MARKETDIN 02241894
BIO-PLEX TAB 0.95MG.95 MGTABLETTHERAPEUTIC FOODS CO.CANCELLED POST MARKETDIN 00760625
CALCIUM & MAGNESIUM PLUS POTASSIUM & ZINC250 MGTABLETNATURAL FACTORS NUTRITIONAL PRODUCTS LTD.CANCELLED POST MARKETDIN 02248650

Who else supplies OTHER MINERAL PRODUCTS worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. OTHER MINERAL PRODUCTS appears in 8 registered pack listings across 2 markets, published on 2 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for ACTI-I CAPLET

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Request a quote for ACTI-I CAPLET

Health Canada Drug Product Database (DPD), DIN 00899127. Last reviewed 2026-09-08. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.